Browsing Tag
National Institutes of Health
19 posts
NIH backs Greenstone Biosciences iPSC and AI programme for Duchenne cardiomyopathy
Greenstone Biosciences has secured a National Institutes of Health R61 award to discover potential treatments for cardiac fibrosis and dilated cardiomyopathy in Duchenne muscular dystrophy, extending its patient-derived stem-cell drug discovery strategy into one of the disease’s most consequential complications.
Greenstone Biosciences wins NHLBI R61 award to identify small-molecule treatments for DMD heart disease
Greenstone Biosciences has secured a $625,968 National Heart, Lung, and Blood Institute (NHLBI) R61 grant to combine patient-derived stem cells, proteomics and artificial intelligence in the search for small-molecule treatments for cardiac fibrosis in Duchenne muscular dystrophy (DMD). The award validates the company’s human-cell-based discovery platform, but target selection, compound validation and progression into the programme’s R33 phase remain critical tests.
Fauci faces DOJ referral after Senate panel advances contempt resolution
A Senate panel advanced an Anthony Fauci contempt resolution, triggering a legal fight over his COVID testimony, pardon and Fifth Amendment rights.
Fauci invokes Fifth Amendment as explosive Rand Paul COVID hearing ends in contempt threat
Fauci invoked the Fifth Amendment at a heated Senate COVID hearing as Rand Paul threatened contempt action over his refusal to testify.
Appili Therapeutics faces funding reset after NIAID terminates VXV-01 contract
Appili Therapeutics faces a funding reset after NIAID ended its VXV-01 contract. Discover what the termination means for APLI investors.
Alzheimer’s blood test breakthrough raises hopes for earlier dementia risk detection
Alzheimer’s may start long before memory loss. Blood tests could shift dementia care from late diagnosis to earlier risk planning.
Could SBS-147 become a credible challenger to opioid-based pain management pathways?
Could SBS-147 challenge opioid-based pain treatment pathways? Read how Sparian Biosciences’ Phase 1 launch could reshape the non-opioid market.
Trump proposes largest military budget in US history at $1.5tn for fiscal 2027
The White House has proposed $1.5 trillion in defense spending for fiscal 2027, the largest military budget request in US history, as the country remains at war with Iran.
Children’s Hospital of Philadelphia study uncovers missing RNA fragments as potential key to targeted immunotherapy for pediatric brain tumors
CHOP researchers discover that missing RNA microexons in pediatric brain tumors create a targetable NRCAM variant, opening new paths for safer immunotherapy.
Virpax Pharmaceuticals extends collaboration with NIH for pain management drug development
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX), a company focused on innovative pharmaceutical solutions for pain management, announced the extension…